
    
      Prospective, randomized multi-center trial of 300 patients will be enrolled at 7 centers in
      Korea. Following angiography, diabetic patients with significant diameter stenosis >50% by
      visual estimation have documented myocardial ischemia or symptoms of angina, and eligible for
      stenting without any exclusion criteria will be randomized 1:1 to: a) Cilotax stent vs. b)
      Xience Prime stent. All patients will be followed for at least 1 year. Angiographic follow-up
      at 9-months is routinely recommended.
    
  